| Description | Enzyme immunoassay for the determination of DHEA-S in human serum and plasma. FDA exempt, can be used for in-vitro diagnostics. | Enzyme immunoassay for the determination of free antibodies to Certolizumab pegol (CZP) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Etanercept (Enbrel®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Tocilizumab (Actemra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of human IGFBP-2 in human serum, EDTA-plasma, cerebrospinal fluid, breast milk, amniotic fluid, saliva, and in cell culture medium. For research use only, not for use in diagnostic procedures. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Assay Time | 1 hour (incubation) | 2 hour, 45 min. total incubation time. | 2 hours, 15 min. total incubation time. | 2 hours, 10 min. total incubation time. | 1 hr 45 mins (incubation) |